Conference registration with arrival tea and coffee


Welcome and official opening

Dr Morris Berrie, Co-Founder/Chairman, TTS Global Initiative

Glenn Cross, CEO, AusBiotech

Dean Moss, CEO, UniQuest


Keynote 1:  The trials and tribulations of running a successful Tech Transfer Office. What’s the end game? Can the launch of the UCL and Apollo collaboration fund change the game?

Cengiz Tarhan, Managing Director, University College London Business (UCLB)


Session 1: Changes in Tech Transfer – the organisation and the personnel

Moderator: Dr Morris Berrie, Co-Founder/Chairman, TTS Global Initiative

Cengiz Tarhan, Managing Director,  University College London Business (UCLB)

Dr Fiona Nelms, ‎Director, Technology Transfer, ‎Australian National University 

Kiara Bechta-Metti, Director, University of Adelaide Enterprise

Shaina Oake, Principle, New Ventures, UCLA, Technology Development Group, USA 


Morning Tea 


Session 2: Big Pharma - What is required to work with big pharma when fundamentally they are based "overseas"? How diligently do you need to manage the relationship?

Moderator: Dr Morris Berrie, Co-Founder/Chairman, TTS Global Initiative

Dr David Thomson, Senior External Affairs Associate, AbbVie

Dr Anand Gautam, Senior Director and Head of External Sciences and Innovation (ES&I), Australia, New Zealand and South-East Asia, Pfizer

Dr Phil Kearney, Director Bd&I, MSD

Dr Andrea Douglas, VP, R&D Strategy and External Affairs, CSL Ltd




Keynote 2: Fine tuning proof of concept funding models and royalty monetisation on the road to commercialisation 

Shaina Oake, Principle, New Ventures, UCLA, Technology Development Group, USA


Session 3: Models for drug discovery and development in academia; understanding and translating the value proposition from an early stage commercialisation perspective

Moderator: Dr Mark Ashton, Executive Director, Intellectual Property Commercialisation, UniQuest

Dr Ashley Bates, Director – Medical Technologies and Pharmaceuticals, AusIndustry - Entrepreneur’s Programme

Dr Andrew Harvey, Senior Director, QEDDI, UniQuest

A Prof Guillaume Lessene, Joint division Head, WEHI

Brett Carter, COO, Cancer Therapeutics CRC

Dr Kathy Nielsen, Senior Commercialisation Manager, Monash University 


Afternoon Tea 


Briefing 1: Analysis. A dirty word in biotech

Stuart Roberts, Senior Analyst, NDF Research  


Session 4: Investor panel

Moderator: Glenn Cross, CEO, AusBiotech

Stuart Roberts, Senior Analyst, NDF Research

Dr Michael Molinari, Investment Manager, Brandon Capital Partners

Dr Peter Devine, CEO, Uniseed Management 

Anne-Marie Birkill, Partner and Executive Director, OneVentures


Networking reception

Supported by:


TTS Australia Dinner

8:30am Conference registration with arrival tea & coffee

Keynote 3: Interview with…

David Blake, Co-Founder, Bioshares


Session 5: Medtech panel

Malcolm Hebblewhite, Commercial Director, Planet Innovation

Paul Carboon, Eco System and Business Development Manager, Hydrix

Ann Damien, New Technology Associate, Cook Medical

Grace Lethlean, Program Director, ANDHealth


Briefing 2: MTPConnect update

Dr Alfredo Martinez-Coll, General Manager, Stakeholder Engagement, MTPConnect


Session 6: Bionomics and Merck case study

Dr Phil Kearny, Director Bd&I, MSD

Dr Deborah Rathjen, CEO and Managing Director, Bionomics


Morning Tea


Session 7: "Preparing for the global stage –the dress rehearsal to opening night".  Readiness to attract investors and partners; tapping into global networks; approaching legal review of your business from a global perspective

Jane Owen, Partner, Bird&Bird

Lyle Abel, Partner, Bird&Bird


Briefing 3: Launch of In-Gage.cn China platform

Rob Scott, Director, China BlueSky Partners


Workshop Presentation:  Better understanding of discounted cash flow and net present value

Dr Patrik Frei, CEO, Venture Valuation Inc., Switzerland

1:50pm TTS Australia closing - followed by lunch with networking

Tweets by @AusBiotech

Major Partner